DRW Securities LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,573 shares of the company’s stock, valued at approximately $503,000.
A number of other institutional investors also recently modified their holdings of HCA. MFA Wealth Advisors LLC bought a new position in HCA Healthcare in the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare during the second quarter valued at approximately $28,000. Bangor Savings Bank lifted its stake in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC increased its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the period. Finally, LifeSteps Financial Inc. bought a new stake in HCA Healthcare during the first quarter valued at $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Stock Performance
Shares of NYSE:HCA opened at $405.71 on Tuesday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $409.42. The company has a market cap of $106.26 billion, a price-to-earnings ratio of 20.22, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a 50-day moving average price of $372.34 and a 200-day moving average price of $341.21.
HCA Healthcare Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.65%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.
Wall Street Analyst Weigh In
HCA has been the subject of a number of research analyst reports. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Morgan Stanley started coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Oppenheimer lifted their price target on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Finally, Wells Fargo & Company raised their price objective on HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a report on Tuesday, July 30th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $359.89.
Check Out Our Latest Research Report on HCA
Insiders Place Their Bets
In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. In the last quarter, insiders have sold 17,202 shares of company stock worth $6,407,273. Company insiders own 1.60% of the company’s stock.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories
- Five stocks we like better than HCA Healthcare
- What is the Australian Securities Exchange (ASX)
- The Average 401k Balance by Age Explained
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Pros And Cons Of Monthly Dividend Stocks
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.